Concepedia

Lei Li

LL

Statistics

Publications

8

Citations

283

H-Index

8

Active since

2020

Affiliations

The First People’s Hospital of Lianyungang(Current)

Lei Li is an author at The First People’s Hospital of Lianyungang specializing in medicine, inflammation, and cell signaling.

ORCID

Top concepts

Publications per year

2020–2023

8

Publications

8

<p>A Novel Serum Exosomes-Based Biomarker hsa_circ_0002130 Facilitates Osimertinib-Resistance in Non-Small Cell Lung Cancer by Sponging miR-498</p>

Jing Ma, Guanbin Qi, Lei Li · OncoTargets and Therapy · 2020 · 66 citations · Full text

CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation

Zhenchuan Liu, Shaorui Gu, Kaiqin Wu et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 54 citations · Full text

CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition

Xianxiong Ma, Hengyu Chen, Lei Li et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 52 citations · Full text

Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression

Shanbao Li, Junyong Weng, Fangbin Song et al. · Cell Death and Disease · 2020 · 47 citations · Full text

Circular RNA circ_0130438 suppresses TNF-α-induced proliferation, migration, invasion and inflammation in human fibroblast-like MH7A synoviocytes by regulating miR-130a-3p/KLF9 axis

Lei Li, Minqing Zhan, Mingwei Li · Transplant Immunology · 2022 · 19 citations

, , +11

1–5 of 8